Published in Afr Health Sci on September 01, 2012
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med (2005) 13.27
Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS (2001) 2.54
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. J Acquir Immune Defic Syndr (2007) 1.90
Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda). Clin Infect Dis (2007) 1.82
Lactic acidosis update for critical care clinicians. J Am Soc Nephrol (2001) 1.78
A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.74
Hypoglycemia at admission is associated with inhospital mortality in Ugandan patients with severe sepsis. Crit Care Med (2011) 1.64
Point-of-care lactate testing predicts mortality of severe sepsis in a predominantly HIV type 1-infected patient population in Uganda. Clin Infect Dis (2008) 1.48
Point-of-care measurement of blood lactate in children admitted with febrile illness to an African District Hospital. Clin Infect Dis (2011) 1.02
Validation of the Accutrend lactate meter for hyperlactatemia screening during antiretroviral therapy in a resource-poor setting. Int J Infect Dis (2008) 1.01
Point of care testing for antiretroviral therapy-related lactic acidosis in resource-poor settings. AIDS (2006) 0.96
Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study. Clin Infect Dis (2003) 0.90
Aggregate evaluable organ dysfunction predicts in-hospital mortality from sepsis in Uganda. Am J Trop Med Hyg (2011) 0.89
Clinical spectrum, morbidity, and mortality of acquired immunodeficiency syndrome in Taiwan: a 5-year prospective study. J Acquir Immune Defic Syndr (2000) 0.85
Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients. Clin Chem (2003) 0.83
Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana. J Antivir Antiretrovir (2011) 0.79
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med (1997) 4.47
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis (1999) 4.18
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS (1999) 3.67
Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med (1998) 3.09
Features of primary care associated with variations in process and outcome of care of people with diabetes. Br J Gen Pract (2001) 2.95
Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 2.70
Rolling out antiretrovirals in Africa: there are still challenges ahead. Clin Infect Dis (2005) 2.43
HIV testing in developing countries. Lancet (1997) 2.19
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J (2009) 2.07
Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis (1999) 2.06
Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage. Haemophilia (2012) 2.05
Management of suspected deep venous thrombosis in outpatients by using clinical assessment and D-dimer testing. Ann Intern Med (2001) 1.93
Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.86
Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health (1998) 1.75
Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis (1999) 1.73
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol Assess (2012) 1.70
Impact of tuberculosis (TB) on HIV-1 activity in dually infected patients. Clin Exp Immunol (2001) 1.67
High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr (1993) 1.64
Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke (2000) 1.59
Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda. Int J STD AIDS (2009) 1.59
The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost (2006) 1.55
Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? Lancet (1996) 1.53
Minimizing errors of omission: behavioural reenforcement of heparin to avert venous emboli: the BEHAVE study. Crit Care Med (2006) 1.52
Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health (1998) 1.44
Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation (2001) 1.43
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study. J Thromb Haemost (2011) 1.42
Ebola hemorrhagic fever and pregnancy. J Infect Dis (1999) 1.41
Euthanasia: from the perspective of HIV infected persons in Europe. HIV Med (2001) 1.40
Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS (1992) 1.39
Isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 1.39
Primary care involvement in human immune deficiency virus infection-a pan-European view. The Eurosupport Study Group. Fam Pract (2000) 1.37
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS (2001) 1.35
Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda. Int J Tuberc Lung Dis (2011) 1.35
Identification and characterization of sera from HIV-infected individuals with broad cross-neutralizing activity against group M (env clade A-H) and group O primary HIV-1 isolates. J Med Virol (2000) 1.31
Who looks after people with diabetes: primary or secondary care? J R Soc Med (2000) 1.30
Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Euro Surveill (2015) 1.28
Evaluation of a clinical case-definition of acquired immunodeficiency syndrome in Africa. Lancet (1987) 1.27
Impact of mouth rinsing before sputum collection on culture contamination. Afr Health Sci (2009) 1.26
Poor performance of hepatitis C antibody tests in hospital patients in Uganda. J Med Virol (2010) 1.25
Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors. AIDS Care (2007) 1.25
Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism. Ann Intern Med (1998) 1.24
Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. J Vasc Surg (1998) 1.21
Endomyocardial fibrosis syndrome in Uganda. Lancet (2000) 1.20
Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Am J Respir Cell Mol Biol (2001) 1.19
Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe. AIDS Care (2004) 1.19
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study. Antivir Ther (2002) 1.19
Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group. AIDS (2000) 1.18
Initiating antiretroviral treatment in a resource-constrained setting: does clinical staging effectively identify patients in need? Int J STD AIDS (2009) 1.18
Persistent diarrhea, strongly associated with HIV infection in Kinshasa, Zaire. Am J Gastroenterol (1987) 1.17
T cell activation, apoptosis and cytokine dysregulation in the (co)pathogenesis of HIV and pulmonary tuberculosis (TB). Clin Exp Immunol (2000) 1.17
Multiple extracellular loop domains contribute critical determinants for agonist binding and activation of the secretin receptor. J Biol Chem (1996) 1.16
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol (1991) 1.15
Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care (2000) 1.14
Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C. Lancet (2000) 1.12
Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost (2006) 1.11
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. Arch Intern Med (1997) 1.11
Male partner voluntary counselling and testing associated with the antenatal services in Kinshasa, Democratic Republic of Congo: a randomized controlled trial. Int J STD AIDS (2011) 1.10
Venous compression syndromes: clinical features, imaging findings and management. Br J Radiol (2013) 1.09
Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugs. AIDS (1999) 1.08
Sexual dysfunction with protease inhibitors. Lancet (1999) 1.07
Families affected by HIV: parents' and children's characteristics and disclosure to the children. AIDS Care (2004) 1.06
Isolation of Candida species on media with and without added fluconazole reveals high variability in relative growth susceptibility phenotypes. Antimicrob Agents Chemother (1997) 1.06
Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol (1999) 1.05
Treatment and prevention of multidrug-resistant tuberculosis. Drugs (1999) 1.05
Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis. Clin Exp Immunol (2005) 1.05
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin Microbiol Infect (2013) 1.04
Prevalence of overweight and obesity in young adults in Uganda. Afr Health Sci (2010) 1.04
Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection. Immunol Lett (1998) 1.04
Hospital based clinical surveillance for dengue haemorrhagic fever in Bandung, Indonesia 1994-1995. Acta Trop (2001) 1.04
Evaluation of the WHO clinical case definition for AIDS in rural Zaire. AIDS (1988) 1.04
Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda. J Med Virol (2010) 1.03
The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor. FEBS Lett (1998) 1.03
Tuberculosis in human immunodeficiency virus infected Ugandan children starting on antiretroviral therapy. Int J Tuberc Lung Dis (2011) 1.01
Uptake of provider-initiated counselling and testing among tuberculosis suspects, Ethiopia. Int J Tuberc Lung Dis (2010) 1.01
Opportunities and barriers for implementation of integrated TB and HIV care in lower level health units: experiences from a rural western Ugandan district. Afr Health Sci (2010) 1.01
Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. Int J Tuberc Lung Dis (2010) 1.00
Distinct cytokine and regulatory T cell profile at pleural sites of dual HIV/tuberculosis infection compared to that in the systemic circulation. Clin Exp Immunol (2011) 1.00
Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia. Ann Soc Belg Med Trop (1995) 1.00
Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda. Int J STD AIDS (2010) 1.00
A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL. J Infect Dis (2011) 1.00
Echocardiographic diagnosis of heart disease in Uganda. Trop Doct (1996) 1.00
Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen. Acta Clin Belg (2006) 0.99
The immune reconstitution inflammatory syndrome related to HIV co-infections: a review. Eur J Clin Microbiol Infect Dis (2011) 0.99
Adrenergic modulation of pancreatic hormone secretion in utero: studies in fetal sheep. Pediatr Res (1980) 0.98
Inequalities in provision of systematic care for patients with diabetes. Fam Pract (2001) 0.96
Greater diversity of HIV-1 quasispecies in HIV-infected individuals with active tuberculosis. J Acquir Immune Defic Syndr (2000) 0.95
Breastfeeding and transmission of HIV. Lancet (1989) 0.95
Superantigen activation of CD4+ and CD8+T cells from HIV-infected subjects: role of costimulatory molecules and antigen-presenting cells (APC) Clin Exp Immunol (1998) 0.95
A guide to GRADE guidelines for the readers of JTH. J Thromb Haemost (2013) 0.94
Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records. J Thromb Haemost (2012) 0.94
Heightened central affective response to visceral sensations of pain and discomfort in IBS. Neurogastroenterol Motil (2009) 0.94
Management of patients with hereditary hypercoagulable disorders. Annu Rev Med (2000) 0.94
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol (1997) 0.94
A Hebbian learning rule gives rise to mirror neurons and links them to control theoretic inverse models. Front Neural Circuits (2013) 0.93
D-dimer testing in pregnant patients: towards determining the next 'level' in the diagnosis of deep vein thrombosis. J Thromb Haemost (2010) 0.93
Determinants of generalized herpes simplex virus-2 epidemics: the role of sexual partner concurrency. Int J STD AIDS (2013) 0.93